c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases

Journal of Pathology

Volumn 206, Issue 3, 2005, Pages 279-290

  Edwards, Samuel T ^a   Cruz, Anthony C ^a   Donnelly, Samantha ^a   Dazin, Paul F ^b   Schulman, Edward S ^c   Jones, Kirk D ^a   Wolters, Paul J ^a,b   Hoopes, Charles ^b   Dolganov, Gregory M ^b   Fang, Kenneth C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

c Kit receptor; Differentiation phenotype; Lung fibrosis; Mast cell; Metalloproteinase

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHYMASE; DISINTEGRIN; FC RECEPTOR; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; SERINE PROTEINASE; STEM CELL FACTOR RECEPTOR; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POPULATION; CELL SELECTION; CELL SUBPOPULATION; CELL SURFACE; CONTROLLED STUDY; CYTOMETRY; FIBROGENESIS; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; LYMPHANGIOLEIOMYOMATOSIS; MAST CELL; MESENCHYME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; TISSUE SPECIFICITY;

CELL DIFFERENTIATION; CELL LINE; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHANGIOLEIOMYOMATOSIS; MAST CELLS; METALLOPROTEASES; PROTO-ONCOGENE PROTEINS C-KIT; PULMONARY FIBROSIS; SARCOIDOSIS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 21344454029     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1780     Document Type: Article

References (55)

1. Austen KF, Boyce JA. Mast cell lineage development and phenotypic regulation. Leuk Res 2001;25(7):511-518.
2. Gibson PG, Allen CJ, Yang JP, et al. Intraepithelial mast cells in allergic and nonallergic asthma: assessment using bronchial brushings. Am Rev Respir Dis 1993;148(1):80-86.
3. Kawanami O, Ferrans VJ, Fulmer JD, Crystal RG. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 1979;40(6):717-734.
4. Hunt LW, Colby TV, Weiler DA, Sur S, Butterfield JH. Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc 1992;67(10):941-8.
5. Walls AF, Bennett AR, Godfrey RC, Holgate ST, Church MK. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin Sci (Lond) 1991;81(2):183-188.
6. Broide DH, Smith CM, Wasserman SI. Mast cells and pulmonary fibrosis: identification of a histamine releasing factor in bronchoalveolar lavage fluid. J Immunol 1990; 145(6):1838-1844.
7. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144(3 Pt 1):706-713.
8. Liebler JM, Qu Z, Buckner B, Powers MR, Rosenbaum JT. Fibroproliferation and mast cells in the acute respiratory distress syndrome. Thorax 1998;53(10):823-829.
9. Schulman ES. The role of mast cells in inflammatory responses in the lung. Crit Rev Immunol 1993;13(1):35-70.
10. Pesci A, Majori M, Piccoli ML, et al. Mast cells in bronchiolitis obliterans organizing pneumonia: mast cell hyperplasia and evidence for extracellular release of tryptase. Chest 1996; 110(2):383-391.
11. Pesci A, Bertorelli G, Gabrielli M, Olivieri D. Mast cells in fibrotic lung disorders. Chest 1993;103(4):989-996.
12. Inoue Y, King TE Jr, Barker E. Daniloff E, Newman LS. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 2002;166(5):765-773.
13. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146(5):1410-1415.
14. Qi JC, Li L, Li Y, et al. An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc epsilon RI(+), tryptase(-), and chymase(-) in a variety of human tissues. J Histochem Cytochem 2003;51(5):643-653.
15. Fireman E, Kivity S, Shahar I, Reshef T, Mekori YA. Secretion of stem cell factor by alveolar fibroblasts in interstitial lung diseases. Immunol Lett 1999;67(3):229-236.
16. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994;144(2):321-328.
17. Frossi B, De Carli M, Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J Leukoc Biol 2004;75(4):579-585.
18. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83(12):4464-4468.
19. Wolters PJ, Pham CT, Muilenburg DJ, Ley TJ, Caughey GH. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem 2001; 276(21):18551-18556.
20. Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC. Tumor necrosis factor-{alpha}-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J Biol Chem 2004;279(7):5612-5620.
21. Fang KC, Raymond WW, Lazarus SC, Caughey GH. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 1996;97(7):1589-1596.
22. Fang KC, Raymond WW, Blount JL, Caughey GH. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 1997; 272(41):25628-25635.
23. Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 1999;162(9):5528-5535.
24. Frank BT, Rossall JC, Caughey GH, Fang KC. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J Immunol 2001; 166(4):2783-2792.
25. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 1999;29(8):2645-2649.
26. Fujita J, Takeuchi T, Dobashi N, Ohtsuki Y, Tokuda M, Takahara J. Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis. Ann Rheum Dis 1999;58(12):770-772.
27. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998;78(6):687-698.
28. Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 2002; 99(9):6292-6297.
29. Hayashi T, Stetler-Stevenson WG, Fleming MV, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996; 149(4):1241-1256.
30. Selman M, Ruiz V, Cabrera S, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis: a prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 2000; 279(3):L562-574.
31. Pardo A, Selman M, Ramirez R, et al. Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. Chest 1992; 102(4):1085-1089.
32. Lemjabbar H, Gosset P, Lechapt-Zalcman E, et al. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 1999; 20(5):903-913.
33. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345(7):517-525.
34. Dolganov GM, Woodruff PG, Novikov AA, et al. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl-cotransporter (NKCC1) in asthmatic subjects. Genome Res 2001;11(9):1473-1483.
35. Woodruff PG, Dolganov GM, Ferrando RE, et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004; 169(9):1001-1006.
36. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 1999;190(2):267-280.
37. Schulman ES, Glaum MC, Post T, et al. ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J Respir Cell Mol Biol 1999;20(3):530-537.
38. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:research0034.1-0034.11.
39. Matsuda R, et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993;142(1):339-346.
40. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 1998;29(5):498-504.
41. Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003;167(10):1410-1415.
42. Butterfield JH, Weiler DA, Hunt LW, Wynn SR, Roche PC. Purification of tryptase from a human mast cell line. J Leukoc Biol 1990;47(5):409-419.
43. Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta. Am Rev Respir Dis 1989; 140(1):95-100.
44. Rose CE Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003;10(3-4):273-288.
45. Haslam PL, Cromwell O, Dewar A, Turner-Warwick M. Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 1981; 44(3):587-593.
46. Jordana M. Mast cells and fibrosis: who's on first? Am J Respir Cell Mol Biol 1993;8(1):7-8.
47. Hawkins RA, Claman HN, Clark RA, Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 1985;102(2):182-186.
48. Flanagan JG, Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 1990; 63(1):185-194.
49. Heard BE, Dewar A, Corrin B. Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis: ultrastructure and cell perimeter measurements. J Pathol 1992;166(3):303-310.
50. Akin C, Metcalfe DD. The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004; 114(1):13-19.
51. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am J Pathol 1994;145(1):114-125.
52. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991;138(5):1257-1265.
53. Tozzi CA, Thakker-Varia S, Yu SY, et al. Mast cell collagenase correlates with regression of pulmonary vascular remodeling in the rat. Am J Respir Cell Mol Biol 1998;18(4):497-510.
54. Coward WR, Okayama Y, Sagara H, Wilson SJ, Holgate ST, Church MK. NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002;169(9):5287-5293.
55. Campbell EM, Charo IF, Kunkel SL, et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J Immunol 1999;163(4):2160-2167.